Zobrazeno 1 - 10
of 11
pro vyhledávání: '"David Hsieh"'
Autor:
Muhammet Ozer, Nina N. Sanford, Salwan S. Al Mutar, Radhika Kainthla, Mohammad Faizan Zahid, Muhammad Shaalan Beg, Aravind Sanjeevaiah, David Hsieh, Udit Verma, Syed Mohammad Ali Kazmi, Amy Little Jones, Suleyman Yasin Goksu
Publikováno v:
Journal of Clinical Oncology. 39:e15516-e15516
e15516 Background: The biology of microsatellite instability-high (MSI-H) in elderly colorectal cancer (CRC) patients is attributed to hypermethylation of promoter region of genes coding for mismatch repair proteins. It is unknown if such patients ar
Autor:
Aparna Kalyan, Chih-Yi Liao, Vaibhav Sahai, David Hsieh, Thomas Enzler, Neehar D. Parikh, Kent A. Griffith
Publikováno v:
Journal of Clinical Oncology. 39:TPS357-TPS357
TPS357 Background: Hepatocellular carcinoma (HCC) is the 4th leading cause of cancer related death worldwide. HCC typically develops in patients with cirrhosis and has a 5-year survival estimate of 20%. Only patients with early stage disease may be e
Autor:
David Hsieh, Nina N. Sanford, Salwan S. Al Mutar, Muhammet Ozer, Syed Mohammad Ali Kazmi, Udit Verma, Muhammad Shaalan Beg, Suleyman Yasin Goksu, Radhika Kainthla, Javier Salgado Pogacnik, Amy Little Jones, Aravind Sanjeevaiah, Craig Olson, Emrah Gumusgoz
Publikováno v:
Journal of Clinical Oncology. 39:40-40
40 Background: Colorectal cancer patients with brain metastases experience poor outcomes; however treatment strategies are understudied. In this study, we investigated the impact of different treatments for colorectal cancer patients with brain metas
Autor:
Muhammad Shaalan Beg, Nina N. Sanford, Todd A. Aguilera, Busra N Bacik Goksu, Suleyman Yasin Goksu, Muhammet Ozer, Aravind Sanjeevaiah, David Hsieh, Syed Mohammad Ali Kazmi, Leticia Khosama
Publikováno v:
Journal of Clinical Oncology. 38:123-123
123 Background: The effect of hospital volume on the outcome of stage 4 pancreatic cancer is not well known. We evaluated the effect of hospital volume on time to treatment and survival in patients with stage 4 pancreatic adenocarcinoma (PDAC). Metho
Autor:
Nina N. Sanford, Todd A. Aguilera, Matthew R. Porembka, Aravind Sanjeevaiah, John C. Mansour, Suleyman Yasin Goksu, David Hsieh, Sam C. Wang, Mary Claire Maxwell, Muhammet Ozer, Muhammad Shaalan Beg, Syed Mohammad Ali Kazmi, Leticia Khosama
Publikováno v:
Journal of Clinical Oncology. 38:e16716-e16716
e16716 Background: Gallbladder cancer (GBC) is an uncommon but highly fatal malignancy. Surgery remains the only potentially curative treatment for GBC. The role of neoadjuvant chemotherapy in patients with locally advanced GBC undergoing surgery is
Autor:
Jessica Saltarski, Farjana J. Fattah, Murtaza Ahmed, Noah Sorrelle, Yvonne Gloria-McCutchen, Saad A. Khan, Shaheen Khan, David Hsieh, David E. Gerber, Jason Y. Park, Rong Lu, Rolf A. Brekken, Mitchell S. von Itzstein, Donglu Xie, Vinita Popat, Benjamin Aaron Bleiberg, Yuqing Zhang, Mary Katherine Watters
Publikováno v:
Journal of Clinical Oncology. 38:e15126-e15126
e15126 Background: The mechanisms by which immune checkpoint inhibitors (ICI) cause immune related adverse events (irAE) are not clear. No current blood tests predict which patients will suffer irAEs. Methods: 70 cancer patients had blood drawn prior
Autor:
Nina N. Sanford, Todd A. Aguilera, Udit Verma, Aravind Sanjeevaiah, Muhammet Ozer, Mary Claire Maxwell, Muslim Atiq, Jonathan Bleeker, Leticia Khosama, Muhammad Shaalan Beg, Suleyman Yasin Goksu, David Hsieh, Syed Mohammad Ali Kazmi
Publikováno v:
Journal of Clinical Oncology. 38:e16710-e16710
e16710 Background: Pancreatic neuroendocrine tumor (PNET) is a rare disease. There is a lack of data on the association of age and sociodemographic characteristics on survival in patients with NET. Our study aimed to evaluate clinical, molecular diff
Autor:
Nina N. Sanford, Todd A. Aguilera, Mary Claire Maxwell, Aravind Sanjeevaiah, David Hsieh, Muhammet Ozer, Suleyman Yasin Goksu, Muhammad Shaalan Beg, Syed Mohammad Ali Kazmi
Publikováno v:
Journal of Clinical Oncology. 38:4056-4056
4056 Background: Anal Squamous Cell Cancer (ASCC) is a highly curable cancer. Underserved and vulnerable populations are particularly at risk of developing this disease. We aimed to study racial disparities and overall survival (OS) in patients with
Autor:
Syed Mohammad Ali Kazmi, Udit Verma, Radhika Kainthla, David Hsieh, Suleyman Yasin Goksu, Nina N. Sanford, Aravind Sanjeevaiah, Linda Farkas, Mohsin Soleja, Amy Little Jones, Muhammad Shaalan Beg
Publikováno v:
Journal of Clinical Oncology. 38:4103-4103
4103 Background: Prior studies have observed under-utilization of adjuvant chemotherapy (ACT) in stage III colon cancer. Our aims were to observe the rate of utilization of ACT in very healthy or “ideal candidates”, identify reasons for omission
Autor:
Mary Claire Maxwell, Udit Verma, Nina N. Sanford, Todd A. Aguilera, Syed Mohammad Ali Kazmi, Suleyman Yasin Goksu, Jonathan Bleeker, Muslim Atiq, David Hsieh, Benjamin D Fangman, Leticia Khosama, Muhammad Shaalan Beg, Aravind Sanjeevaiah, Radhika Kainthla
Publikováno v:
Journal of Clinical Oncology. 38:674-674
674 Background: Young-onset pancreatic adenocarcinoma (YOPC) is uncommon but there are limited studies for these patients. We used a population based registry to compare the characteristics and outcomes of young-onset vs. older patients with pancreat